INS and type 1 diabetes mellitus: In recent years, interest in understanding the immunological mechanisms underlying type 1 diabetes has increased, in turn leading to a heightened focus on addressing the primary pathology, which involves the immunological destruction of insulin-producing beta cells in the pancreas.